DeniLA: Comprehensive demographics and clinical profile of NSCLC patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

Trial Identifier:	D133FR00224
Sponsor:	AstraZeneca
Start Date:	November 2025
Primary Completion Date:	April 2027
Study Completion Date:	April 2027
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Recife, Brazil
Brazil	Rio de Janeiro, Brazil
Brazil	Salvador, Brazil
Brazil	Sao Paulo, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.